Scans showing cancer left unread for weeks at NHS hospitals

Radiological scans showing cancer are falling by the wayside at National Health Service (NHS) hospitals, with some going unread for up to six weeks because of a pension dispute between doctors and England’s public health arm.

“Scan report turnaround time has gone from one week to over a month. Unexpected and critical findings are going unreported for weeks. We are now just firefighting,” said an unnamed consultant radiologist in the report published by the Guardian.

Hospitals have cut services as thousands of consultant radiologists stop taking on overtime in order to avoid paying unexpected tax bills on their pensions, according to the Guardian.

“Radiology waiting times are unacceptable, with [delays of] five to six weeks for cancer patients on treatment to get a report,” said one consultant, in a report of more than 1,000 consultants across the UK collected by the Hospital Consultants and Specialists Association (HCSA).

According to the Guardian, the Department of Health and Social Care will look at potential solutions, and its health secretary, Matt Hancock, vowed to remedy the situation before the April 2020 tax year begins.

Read the entire story below.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.